Mozobil
Term · Oncology and biomedicine · MLC-T-ONC-005519
A drug used with granulocyte colony-stimulating factor before an autologous stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. It is also being studied in the treatment of other types of cancer. Mozobil helps move stem cells from the bone marrow to the blood so they can be collected, stored, and then given back to the patient. Mozobil is a type of hematopoietic stem cell mobilizer. Also called AMD 3100 and plerixafor.
| Identifier | MLC-T-ONC-005519 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AMD 3100; plerixafor |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005519",
"term": "Mozobil",
"field": "Oncology and biomedicine",
"definition": "A drug used with granulocyte colony-stimulating factor before an autologous stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. It is also being studied in the treatment of other types of cancer. Mozobil helps move stem cells from the bone marrow to the blood so they can be collected, stored, and then given back to the patient. Mozobil is a type of hematopoietic stem cell mobilizer. Also called AMD 3100 and plerixafor.",
"synonyms": [
"AMD 3100",
"plerixafor"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mozobil/"
}
Record 11,306 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.